What we treat

Age-related macular degeneration (AMD)

AMD (age-related macular degeneration) is a disorder that affects the central part of the retina called the macula. Due to its progressive character, it usually leads to significant eyesight deterioration or complete blindness. AMD is related to aging and cell degeneration; therefore, it most often affects persons over 50 years old in developed countries. The disease occurs in two forms, dry and wet.

  • blurred central vision (grey or dark spot in the centre of the visual field),
  • reduced contrast sensation,
  • „warping” of straight lines,
  • progressive (typically in dry form) or sudden (wet form) vision deterioration.

In the case of suspected AMD, our doctors have access to numerous specialist examinations, e.g.:

  • Angio OCT,
  • OCT, i.e. optical coherence tomography,
  • Fluorescein angiography.

1. Dry form of AMD

Adequate diet and supplements rich in suitable vitamins, minerals, lutein, and omega-3 fatty acids can slow down the progress of AMD.

2. Wet form of AMD

In Delavi, we use of the most effective therapies, i.e. intravitreal injections of anti-VEGF preparations. The treatment with these drugs involves a series of injections into the vitreous chamber of the eye. This is the only method of treatment of wet AMD; the sooner it starts, the better is the prognosis regarding improvement or maintenance of the eye function. The procedure is painless and is conducted in the operating block setting.

Postoperative instructions:

  • antibiotic in eye drops for 7 days,
  • follow-up as instructed by the doctor,
  • immediate contact with the Ophthalmology Centre in the event of vision deterioration.